Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 18, 2002
Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival
Eileen D Adamson, Dan Mercola
The Prostate
|
January 7, 2005
Co-factors p300 and CBP catch Egr1 in their network
Eileen D Adamson, Jianxiu Yu, Tomas Mustelin
Journal of Cellular Physiology
|
February 22, 2002
Cripto: a tumor growth factor and more
Eileen D Adamson, Gabriella Minchiotti, David S Salomon
Molecular Cell
|
July 1, 2004
Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses
Jianxiu Yu, Ian de Belle, Hongyan Liang, et al.
The Journal of Biological Chemistry
|
December 8, 2004
Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2
M Cecilia Subauste, Perihan Nalbant, Eileen D Adamson, et al.
The Journal of Biological Chemistry
|
February 4, 2003
In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1
Ian De Belle, Jie-Xin Wu, Sabina Sperandio, et al.
The Journal of Biological Chemistry
|
January 31, 2003
Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes
Thierry Virolle, Anja Krones-Herzig, Veronique Baron, et al.
The Journal of Cell Biology
|
October 29, 2003
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells
Silvia Parisi, Daniela D'Andrea, Carmine T Lago, et al.
The Journal of Cell Biology
|
May 13, 2004
Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility
M Cecilia Subauste, Olivier Pertz, Eileen D Adamson, et al.
Cancer Research
|
June 17, 2005
Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53
Anja Krones-Herzig, Shalu Mittal, Kelly Yule, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 18, 2002
Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival
Eileen D Adamson, Dan Mercola
The Prostate
|
January 7, 2005
Co-factors p300 and CBP catch Egr1 in their network
Eileen D Adamson, Jianxiu Yu, Tomas Mustelin
Journal of Cellular Physiology
|
February 22, 2002
Cripto: a tumor growth factor and more
Eileen D Adamson, Gabriella Minchiotti, David S Salomon
Molecular Cell
|
July 1, 2004
Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses
Jianxiu Yu, Ian de Belle, Hongyan Liang, et al.
The Journal of Biological Chemistry
|
December 8, 2004
Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2
M Cecilia Subauste, Perihan Nalbant, Eileen D Adamson, et al.
The Journal of Biological Chemistry
|
February 4, 2003
In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1
Ian De Belle, Jie-Xin Wu, Sabina Sperandio, et al.
The Journal of Biological Chemistry
|
January 31, 2003
Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes
Thierry Virolle, Anja Krones-Herzig, Veronique Baron, et al.
The Journal of Cell Biology
|
October 29, 2003
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells
Silvia Parisi, Daniela D'Andrea, Carmine T Lago, et al.
The Journal of Cell Biology
|
May 13, 2004
Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility
M Cecilia Subauste, Olivier Pertz, Eileen D Adamson, et al.
Cancer Research
|
June 17, 2005
Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53
Anja Krones-Herzig, Shalu Mittal, Kelly Yule, et al.
Page
of 2